These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


326 related items for PubMed ID: 16700814

  • 21. The use of toxicogenomic data in risk assessment: a regulatory perspective.
    Chan VS, Theilade MD.
    Clin Toxicol (Phila); 2005; 43(2):121-6. PubMed ID: 15822767
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. The Japanese toxicogenomics project: application of toxicogenomics.
    Uehara T, Ono A, Maruyama T, Kato I, Yamada H, Ohno Y, Urushidani T.
    Mol Nutr Food Res; 2010 Feb; 54(2):218-27. PubMed ID: 20041446
    [Abstract] [Full Text] [Related]

  • 24. Prediction and classification of drug toxicity using probabilistic modeling of temporal metabolic data: the consortium on metabonomic toxicology screening approach.
    Ebbels TM, Keun HC, Beckonert OP, Bollard ME, Lindon JC, Holmes E, Nicholson JK.
    J Proteome Res; 2007 Nov; 6(11):4407-22. PubMed ID: 17915905
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Creation of a digital slide and tissue microarray resource from a multi-institutional predictive toxicology study in the rat: an initial report from the PredTox group.
    Mulrane L, Rexhepaj E, Smart V, Callanan JJ, Orhan D, Eldem T, Mally A, Schroeder S, Meyer K, Wendt M, O'Shea D, Gallagher WM.
    Exp Toxicol Pathol; 2008 Aug; 60(4-5):235-45. PubMed ID: 18479893
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Chemogenomic analysis of safety profiling data.
    Scheiber J, Jenkins JL.
    Methods Mol Biol; 2009 Aug; 575():207-23. PubMed ID: 19727617
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Application of emerging technologies in toxicology and safety assessment: regulatory perspectives.
    Leighton JK.
    Int J Toxicol; 2005 Aug; 24(3):153-5. PubMed ID: 16040567
    [Abstract] [Full Text] [Related]

  • 31. Toxicogenomics: a pivotal piece in the puzzle of toxicological research.
    Gatzidou ET, Zira AN, Theocharis SE.
    J Appl Toxicol; 2007 Aug; 27(4):302-9. PubMed ID: 17429800
    [Abstract] [Full Text] [Related]

  • 32. Understanding mechanisms of toxicity: insights from drug discovery research.
    Houck KA, Kavlock RJ.
    Toxicol Appl Pharmacol; 2008 Mar 01; 227(2):163-78. PubMed ID: 18063003
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Current challenges in the evaluation of cardiac safety during drug development: translational medicine meets the Critical Path Initiative.
    Piccini JP, Whellan DJ, Berridge BR, Finkle JK, Pettit SD, Stockbridge N, Valentin JP, Vargas HM, Krucoff MW, CSRC/HESI Writing Group.
    Am Heart J; 2009 Sep 01; 158(3):317-26. PubMed ID: 19699852
    [Abstract] [Full Text] [Related]

  • 37. Identification and elucidation of the biology of adverse events: the challenges of safety assessment and translational medicine.
    Turteltaub KW, Davis MA, Burns-Naas LA, Lawton MP, Clark AM, Reynolds JA.
    Clin Cancer Res; 2011 Nov 01; 17(21):6641-5. PubMed ID: 22046025
    [Abstract] [Full Text] [Related]

  • 38. Toxicogenomics--a new systems toxicology approach to understanding of gene-environment interactions.
    Olden K.
    Ann N Y Acad Sci; 2006 Sep 01; 1076():703-6. PubMed ID: 17119247
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 17.